Literature DB >> 11277322

Linkage of persistent cholangitis after bilioenterostomy with biliary carcinogenesis in hamsters.

T Kitajima1, Y Tajima, S Onizuka, S Matsuzaki, K Matsuo, T Kanematsu.   

Abstract

Biliary carcinoma occurring after bilioenterostomy has been reported as a late complication of this surgical procedure. The present study was designed to determine if bilioenterostomy promotes biliary carcinogenesis, and also to clarify the relationship between biliary inflammation and biliary carcinogenesis in hamsters. Syrian hamsters underwent a simple laparotomy (SL), choledochoduodenostomy (CD) or choledochojejunostomy (CJ). All hamsters received subcutaneous injections of the chemical carcinogen, N-nitrosobis (2-oxopropyl) amine (BOP), and were sacrificed 20 weeks after surgery. Neoplastic lesions in the biliary tree were histologically examined, and the presence and degree of cholangitis was also evaluated with special reference to biliary carcinogenesis. The incidence of bile duct carcinoma was not significantly different among the three groups. Numerous bile duct carcinomas, however, were recognized in the bilioenterostomized animals, especially in the CJ group. Moreover, significant correlations between biliary carcinogenesis and the presence of cholangitis were noted in both the CD and CJ groups, but not in the SL control group. Severe cholangitis was evident in the CJ group, and the number of biliary carcinomas was well correlated with the degree of cholangitis. In conclusion, the risk of carcinoma in the biliary tract may increase when persistent cholangitis is present after biliary reconstruction.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11277322

Source DB:  PubMed          Journal:  J Exp Clin Cancer Res        ISSN: 0392-9078


  1 in total

1.  Inflammatory cytokines promote inducible nitric oxide synthase-mediated DNA damage in hamster gallbladder epithelial cells.

Authors:  Amane Kitasato; Yoshitsugu Tajima; Tamotsu Kuroki; Ryuji Tsutsumi; Tomohiko Adachi; Takehiro Mishima; Takashi Kanematsu
Journal:  World J Gastroenterol       Date:  2007-12-21       Impact factor: 5.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.